Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Urayasu, Japan.
J Diabetes Investig. 2023 Jun;14(6):811-820. doi: 10.1111/jdi.14008. Epub 2023 Mar 20.
For long-term management of diabetes, patients with type 2 diabetes mellitus require a high level of treatment adherence, which is associated with treatment satisfaction and their quality of life (QOL). To achieve it, patient education about diabetes self-management is essential. We routinely conduct a 7 day inpatient diabetes education program and administer the diabetes treatment-related (DTR)-QOL questionnaire to all participants, both before admission and at discharge. Here, we investigated whether our program improves QOL and post-discharge glycemic control.
This retrospective study utilized data from patients with type 2 diabetes mellitus who participated in our program between July 2017 and March 2020 and who had been treated in our outpatient department for more than 1 year. We evaluated the relationship between at admission and at discharge diabetes treatment-related quality of life scores and glycemic control after discharge.
Data from 140 patients were analyzed in this study, which showed a significant improvement in the total, 'Anxiety and dissatisfaction with treatment', and 'Satisfaction-with-treatment' scores. A significant improvement was evident in HbA1c at 12 months after discharge. Multiple regression analysis showed that HbA1c after 12 months was independently associated with gender, duration of diabetes, and HbA1c at admission.
Our program effectively improves quality of life and post-discharge glycemic control in patients with type 2 diabetes mellitus. It is particularly effective in patients of the male gender, with a shorter duration of diabetes mellitus and higher HbA1c at admission.
对于 2 型糖尿病患者的长期管理,需要高水平的治疗依从性,这与治疗满意度和生活质量(QOL)有关。为了实现这一目标,对糖尿病自我管理的患者教育至关重要。我们常规开展 7 天住院糖尿病教育计划,并在所有参与者入院前和出院时管理糖尿病治疗相关(DTR)-QOL 问卷。在这里,我们调查了我们的计划是否可以改善 QOL 和出院后血糖控制。
这项回顾性研究使用了 2017 年 7 月至 2020 年 3 月期间参加我们计划的 2 型糖尿病患者的数据,这些患者在我们的门诊接受治疗已超过 1 年。我们评估了入院时和出院时糖尿病治疗相关生活质量评分与出院后血糖控制之间的关系。
本研究共分析了 140 例患者的数据,结果显示总体、“对治疗的焦虑和不满”和“对治疗的满意度”评分均有显著改善。出院后 12 个月时 HbA1c 明显改善。多元回归分析显示,HbA1c 在 12 个月后与性别、糖尿病病程和入院时 HbA1c 独立相关。
我们的计划可有效改善 2 型糖尿病患者的生活质量和出院后血糖控制。对于性别为男性、糖尿病病程较短和入院时 HbA1c 较高的患者效果更为显著。